Stay updated with breaking news from Alpine Immune Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Alpine Immune Sciences (NASDAQ: ALPN) has recently received a number of price target changes and ratings updates: 9/1/2023 – Alpine Immune Sciences had its “outperform” rating reaffirmed by analysts at Wedbush. They now have a $19.00 price target on the stock. 8/31/2023 – Alpine Immune Sciences had its “buy” rating reaffirmed by analysts at HC […]
Alpine Immune Sciences (NASDAQ:ALPN – Get Free Report)‘s stock had its “outperform” rating restated by equities researchers at Wedbush in a research note issued to investors on Friday, Benzinga reports. They presently have a $19.00 target price on the biotechnology company’s stock. Wedbush’s price objective would suggest a potential upside of 47.29% from the stock’s […]
Alpine Immune Sciences Stock (NASDAQ: ALPN) stock price, news, charts, stock research, profile.
/PRNewswire/ -- DelveInsight's Cutaneous Lupus Erythematosus Market Insights report includes a comprehensive understanding of current treatment practices,...